![Thomas Civik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Civik
Directeur Général chez
PYXIS ONCOLOGY, INC.
Fortune : 718 911 $ au 31/08/2026
Profil
Thomas Civik is Chairman & Chief Executive Officer at Pyxis Oncology, Inc. since 2026.
Formerly, Mr. Civik was President, Chief Executive Officer & Director at Five Prime Therapeutics, Inc. from 2020 to 2021.
Mr. Civik served as Independent Chairman at Repare Therapeutics, Inc. from 2021 to 2026 and at Imcheck Therapeutics SAS. Mr. Civik was Vice President-Avastin Sales & Marketing at Genentech, Inc. from 2000 to 2017.
Mr. Civik was Chief Commercial Officer at Foundation Medicine, Inc. from 2017 to 2019.
Education includes undergraduate studies at St. Norbert College, Inc. and an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PYXIS ONCOLOGY, INC. 0,27 % | 04/09/2026 | 221 886 ( 0,27 % ) | 718 911 $ | 31/08/2026 |
Postes actifs de Thomas Civik
| Sociétés | Poste | Début |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Directeur Général | 03/02/2026 |
Anciens postes connus de Thomas Civik
| Sociétés | Poste | Fin |
|---|---|---|
| REPARE THERAPEUTICS INC. | Président | 28/01/2026 |
| FIVE PRIME THERAPEUTICS, INC. | Directeur Général | 16/04/2021 |
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | 01/09/2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Sales & Marketing | 01/11/2017 |
Imcheck Therapeutics SAS
 Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Président | - |
Formation de Thomas Civik
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
St. Norbert College, Inc.
 St. Norbert College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Health Technology |
Repare Therapeutics, Inc.
 Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer therapies | Health Technology |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
